|
Rep. JoAnn D. Osmond
Filed: 2/27/2014
| | 09800HB3645ham001 | | LRB098 12715 RPS 56061 a |
|
|
1 | | AMENDMENT TO HOUSE BILL 3645
|
2 | | AMENDMENT NO. ______. Amend House Bill 3645 as follows:
|
3 | | on page 8, immediately below line 26, by inserting the |
4 | | following: |
5 | | "Section 12. The Nursing Home Care Act is amended by |
6 | | changing Section 2-104 as follows:
|
7 | | "(210 ILCS 45/2-104) (from Ch. 111 1/2, par. 4152-104)
|
8 | | Sec. 2-104.
(a) A resident shall be permitted to retain the |
9 | | services
of his own personal physician at his own expense or |
10 | | under an individual or
group plan of health insurance, or under |
11 | | any public or private
assistance program providing such |
12 | | coverage. However, the facility is
not liable for the |
13 | | negligence of any such personal physician. If a resident |
14 | | retains the services of a naturopathic physician as his |
15 | | personal physician, the resident's care must be overseen by a |
|
| | 09800HB3645ham001 | - 2 - | LRB098 12715 RPS 56061 a |
|
|
1 | | physician licensed to practice medicine in all of its branches |
2 | | in accordance with a written agreement between the physicians. |
3 | | The Department shall adopt rules setting forth the minimum |
4 | | requirements for such an agreement. Every
resident shall be |
5 | | permitted to obtain from his own physician or the
physician |
6 | | attached to the facility complete and current information
|
7 | | concerning his medical diagnosis, treatment and prognosis in |
8 | | terms and
language the resident can reasonably be expected to |
9 | | understand. Every
resident shall be permitted to participate in |
10 | | the planning of his total
care and medical treatment to the |
11 | | extent that his condition permits. No
resident shall be |
12 | | subjected to experimental research or treatment
without first |
13 | | obtaining his informed, written consent. The conduct of
any |
14 | | experimental research or treatment shall be authorized and |
15 | | monitored
by an institutional review board appointed by the |
16 | | Director. The
membership, operating procedures and review |
17 | | criteria for the institutional
review board shall be prescribed |
18 | | under rules and regulations of the
Department and shall comply |
19 | | with the requirements for institutional review boards |
20 | | established by the federal Food and Drug Administration. No |
21 | | person who has received compensation in the prior 3 years from |
22 | | an entity that manufactures, distributes, or sells |
23 | | pharmaceuticals, biologics, or medical devices may serve on the |
24 | | institutional review board. |
25 | | The institutional review board may approve only research or |
26 | | treatment that meets the standards of the federal Food and Drug |
|
| | 09800HB3645ham001 | - 3 - | LRB098 12715 RPS 56061 a |
|
|
1 | | Administration with respect to (i) the protection of human |
2 | | subjects and (ii) financial disclosure by clinical |
3 | | investigators. The Office of State Long Term Care Ombudsman and |
4 | | the State Protection and Advocacy organization shall be given |
5 | | an opportunity to comment on any request for approval before |
6 | | the board makes a decision. Those entities shall not be |
7 | | provided information that would allow a potential human subject |
8 | | to be individually identified, unless the board asks the |
9 | | Ombudsman for help in securing information from or about the |
10 | | resident. The board shall require frequent reporting of the |
11 | | progress of the approved research or treatment and its impact |
12 | | on residents, including immediate reporting of any adverse |
13 | | impact to the resident, the resident's representative, the |
14 | | Office of the State Long Term Care Ombudsman, and the State |
15 | | Protection and Advocacy organization. The board may not approve |
16 | | any retrospective study of the records of any resident about |
17 | | the safety or efficacy of any care or treatment if the resident |
18 | | was under the care of the proposed researcher or a business |
19 | | associate when the care or treatment was given, unless the |
20 | | study is under the control of a researcher without any business |
21 | | relationship to any person or entity who could benefit from the |
22 | | findings of the study. |
23 | | No facility shall permit experimental research or |
24 | | treatment to be conducted on a resident, or give access to any |
25 | | person or person's records for a retrospective study about the |
26 | | safety or efficacy of any care or treatment, without the prior |
|
| | 09800HB3645ham001 | - 4 - | LRB098 12715 RPS 56061 a |
|
|
1 | | written approval of the institutional review board. No nursing |
2 | | home administrator, or person licensed by the State to provide |
3 | | medical care or treatment to any person, may assist or |
4 | | participate in any experimental research on or treatment of a |
5 | | resident, including a retrospective study, that does not have |
6 | | the prior written approval of the board. Such conduct shall be |
7 | | grounds for professional discipline by the Department of |
8 | | Financial and
Professional Regulation. |
9 | | The institutional review board may exempt from ongoing |
10 | | review research or treatment initiated on a resident before the |
11 | | individual's admission to a facility and for which the board |
12 | | determines there is adequate ongoing oversight by another |
13 | | institutional review board. Nothing in this Section shall |
14 | | prevent a facility, any facility employee, or any other person |
15 | | from assisting or participating in any experimental research on |
16 | | or treatment of a resident, if the research or treatment began |
17 | | before the person's admission to a facility, until the board |
18 | | has reviewed the research or treatment and decided to grant or |
19 | | deny approval or to exempt the research or treatment from |
20 | | ongoing review.
|
21 | | (b) All medical treatment and procedures shall be |
22 | | administered as
ordered by a physician. All new physician |
23 | | orders shall be reviewed by the
facility's director of nursing |
24 | | or charge nurse designee within 24 hours
after such orders have |
25 | | been issued to assure facility compliance with such orders.
|
26 | | All physician's orders and plans of treatment shall have |
|
| | 09800HB3645ham001 | - 5 - | LRB098 12715 RPS 56061 a |
|
|
1 | | the authentication of the physician. For the purposes of this |
2 | | subsection (b), "authentication" means an original written |
3 | | signature or an electronic signature system that allows for the |
4 | | verification of a signer's credentials. A stamp signature, with |
5 | | or without initials, is not sufficient. |
6 | | According to rules adopted by the Department, every woman |
7 | | resident of
child-bearing age shall receive routine |
8 | | obstetrical and gynecological
evaluations as well as necessary |
9 | | prenatal care.
|
10 | | (c) Every resident shall be permitted to refuse medical |
11 | | treatment
and to know the consequences of such action, unless |
12 | | such refusal would
be harmful to the health and safety of |
13 | | others and such harm is
documented by a physician in the |
14 | | resident's clinical record. The
resident's refusal shall free |
15 | | the facility from the obligation to
provide the treatment.
|
16 | | (d) Every resident, resident's guardian, or parent if the |
17 | | resident
is a minor shall be permitted to inspect and copy all |
18 | | his clinical and
other records concerning his care and |
19 | | maintenance kept by the facility
or by his physician. The |
20 | | facility may charge a reasonable fee for
duplication of a |
21 | | record.
|
22 | | (Source: P.A. 96-1372, eff. 7-29-10; 97-179, eff. 1-1-12.)".
|